MedPath
HSA Approval

CLODERM CREAM 0.05% w/w

SIN10241P

CLODERM CREAM 0.05% w/w

CLODERM CREAM 0.05% w/w

October 10, 1998

ZUELLIG PHARMA PTE. LTD.

ZUELLIG PHARMA PTE. LTD.

Regulatory Information

ZUELLIG PHARMA PTE. LTD.

ZUELLIG PHARMA PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

CREAM

**RECOMMENDED DOSAGE :** Wash and dry affected area. Apply Cloderm Cream sparingly to the affected areas and rub in once or twice daily as directed by your doctor or pharmacist. If symptoms persist, please consult your doctor or pharmacist. This preparation is for the treatment of your current condition only. Do not allow use by any other person and dispose of unused material when your treatment is complete.

TOPICAL

Medical Information

**INDICATIONS :** For short-term treatment of inflammatory and pruritic manifestations of moderate to severe corticosteroid - responsive dermatoses.

**CONTRAINDICATIONS :** Hypersensitivity to the preparation, rosacea, acne vulgaris, peri-oral dermatitis, primary cutaneous viral infections (eg. herpes simplex, chicken pox). The use of Cloderm Cream is not indicated in the treatment of primary infected skin lesions caused by infection with fungi (eg. candidiasis, tinea), or bacteria (eg. impetigo), peri-anal and genital pruritus. Not recommended for infants under 1 year of age.

D07AD01

clobetasol

Manufacturer Information

ZUELLIG PHARMA PTE. LTD.

HOE PHARMACEUTICALS SDN BHD

Active Ingredients

CLOBETASOL PROPIONATE EQV CLOBETASOL

0.5 mg/g

Clobetasol propionate

Documents

Package Inserts

CLODERM PI.pdf

Approved: May 24, 2021

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CLODERM CREAM 0.05% w/w - HSA Approval | MedPath